Marker Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY1999 | — | $100.4K | — |
| FY2000 | — | $252.2K | — |
| FY2001 | — | $-74.0K | — |
| FY2002 | — | $465.8K | — |
| FY2003 | — | $-643.7K | — |
| FY2004 | — | $-2.4M | — |
| FY2005 | — | $-2.2M | — |
| FY2006 | — | $-3.0M | — |
| FY2007 | — | $-1.7M | — |
| FY2008 | — | $-3.0M | — |
| FY2009 | — | $-1.8M | — |
| FY2010 | — | $-3.9M | — |
| FY2011 | — | $-3.5M | — |
| FY2012 | — | $-6.0M | — |
| FY2013 | — | $-8.8M | — |
| FY2014 | — | $-1.0M | — |
| FY2015 | — | $-21.4M | — |
| FY2016 | — | $6.2M | — |
| FY2017 | — | $3.7M | $5.1M |
| FY2018 | — | $59.3M | $61.7M |
| FY2019 | — | $44.1M | $43.9M |
| FY2020 | — | $27.3M | $21.4M |
| FY2021 | — | $44.0M | $42.4M |
| FY2022 | — | $19.6M | $11.8M |
| FY2023 | — | $14.1M | $15.1M |
| FY2024 | — | $18.6M | $19.2M |
| FY2025 | — | $16.8M | $16.1M |